Search Results Search Sort by RelevanceMost Recent Case and Commentary Feb 2022 How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work? Tabitha E. H. Moses, MS and Arash Javanbakht, MD Clinicians with obligations to patients and to organizations often assess patients in law enforcement for both therapeutic and nontherapeutic purposes. AMA J Ethics. 2022;24(2):E111-119. doi: 10.1001/amajethics.2022.111. Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 1 Amy Haddad, PhD, RN Virtual Mentor. 2002;4(11):320-323. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211. Policy Forum Jan 2022 La equidad sanitaria necesita una dentadura Eleanor Fleming, PhD, MPH, Julie Hawley, PhD, and Myechia Minter-Jordan, MD, MBA AMA J Ethics. 2022;E48-56. doi: 10.1001/amajethics.2022.48. Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 2 Audiey Kao, MD, PhD Virtual Mentor. 2002;4(11):324-326. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211. Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557. Case and Commentary Aug 2021 How Should Willingness-to-Pay Values of Quality-Adjusted Life-Years Be Updated and According to Whom? Paul T. Menzel, PhD Justification for using WTP values and QALYs lies in incorporating preferences of those whose treatment could be affected. AMA J Ethics. 2021;23(8):E601-606. doi: 10.1001/amajethics.2021.601. Case and Commentary Aug 2021 How Should Economic Value Be Considered in Treatment Decisions for Individual Patients? Hadley Stevens Smith, PhD, MPSA Physicians’ primary responsibility is to promote patients’ well-being, which includes not causing financial harm. AMA J Ethics. 2021;23(8):E607-612. doi: 10.1001/amajethics.2021.607. Medical Education Aug 2021 How Should Economic Evaluation Be Used to Measure Value and Set Priorities in Health Care? Sahan Jayawardana, MSc and Elias Mossialos, MD, PhD Novel interventions that are effective and safe but costly suggest the importance of questions about value, accessibility, and affordability. AMA J Ethics. 2021;23(8):E613-618. doi: 10.1001/amajethics.2021.613. In the Literature Aug 2021 “Perspectives” in Health Technology Assessment Anthony J. Culyer, DEcon Whether any particular perspective is the right one is contingent upon conditions in which the analysis is to be applied. AMA J Ethics. 2021;23(8):E619-623. doi: 10.1001/amajethics.2021.619. State of the Art and Science Aug 2021 How Economic Decision Modeling Can Facilitate Health Equity Jeffrey S. Hoch, PhD, Logan Trenaman, PhD, Shannon M. Hearney, MPH, and Carolyn S. Dewa, PhD, MPH Modeling how technology assessment fits into cost-effectiveness frameworks can broaden the range of options for improving health equity. AMA J Ethics. 2021;23(8):E624-630. doi: 10.1001/amajethics.2021.624. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Feb 2022 How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work? Tabitha E. H. Moses, MS and Arash Javanbakht, MD Clinicians with obligations to patients and to organizations often assess patients in law enforcement for both therapeutic and nontherapeutic purposes. AMA J Ethics. 2022;24(2):E111-119. doi: 10.1001/amajethics.2022.111.
Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 1 Amy Haddad, PhD, RN Virtual Mentor. 2002;4(11):320-323. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211.
Policy Forum Jan 2022 La equidad sanitaria necesita una dentadura Eleanor Fleming, PhD, MPH, Julie Hawley, PhD, and Myechia Minter-Jordan, MD, MBA AMA J Ethics. 2022;E48-56. doi: 10.1001/amajethics.2022.48.
Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 2 Audiey Kao, MD, PhD Virtual Mentor. 2002;4(11):324-326. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211.
Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557.
Case and Commentary Aug 2021 How Should Willingness-to-Pay Values of Quality-Adjusted Life-Years Be Updated and According to Whom? Paul T. Menzel, PhD Justification for using WTP values and QALYs lies in incorporating preferences of those whose treatment could be affected. AMA J Ethics. 2021;23(8):E601-606. doi: 10.1001/amajethics.2021.601.
Case and Commentary Aug 2021 How Should Economic Value Be Considered in Treatment Decisions for Individual Patients? Hadley Stevens Smith, PhD, MPSA Physicians’ primary responsibility is to promote patients’ well-being, which includes not causing financial harm. AMA J Ethics. 2021;23(8):E607-612. doi: 10.1001/amajethics.2021.607.
Medical Education Aug 2021 How Should Economic Evaluation Be Used to Measure Value and Set Priorities in Health Care? Sahan Jayawardana, MSc and Elias Mossialos, MD, PhD Novel interventions that are effective and safe but costly suggest the importance of questions about value, accessibility, and affordability. AMA J Ethics. 2021;23(8):E613-618. doi: 10.1001/amajethics.2021.613.
In the Literature Aug 2021 “Perspectives” in Health Technology Assessment Anthony J. Culyer, DEcon Whether any particular perspective is the right one is contingent upon conditions in which the analysis is to be applied. AMA J Ethics. 2021;23(8):E619-623. doi: 10.1001/amajethics.2021.619.
State of the Art and Science Aug 2021 How Economic Decision Modeling Can Facilitate Health Equity Jeffrey S. Hoch, PhD, Logan Trenaman, PhD, Shannon M. Hearney, MPH, and Carolyn S. Dewa, PhD, MPH Modeling how technology assessment fits into cost-effectiveness frameworks can broaden the range of options for improving health equity. AMA J Ethics. 2021;23(8):E624-630. doi: 10.1001/amajethics.2021.624.